SCHEDULE 13G Filed 2026-09-01 Event — SEC 0001104659-26-104386 →

INTEGRATED CORE STRATEGIES (US) LLC → Fortress Biotech, Inc. FBIOP

Stake: — Shares: — CUSIP: 34960Q307 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.00

1,600 shares short · +100.0% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-06-22	Jin David	officer	Award	400,000	—	—

Other 13D/G Filings on Fortress Biotech, Inc.

Filed	Form	Filer	Stake	Shares
2024-01-03	SC	ROSENWALD LINDSAY A MD	—	—	view →

Other Filings by INTEGRATED CORE STRATEGIES (US) LLC

Filed	Form	Issuer	Stake	Shares
2026-10-05	SCHEDULE 13G	First Horizon Corporation	—	—	view →
2026-09-22	SCHEDULE 13G	Better Home & Finance Holding Company	—	—	view →
2026-09-04	SCHEDULE 13G	Karyopharm Therapeutics Inc.	—	—	view →
2026-08-24	SCHEDULE 13G	Collegium Pharmaceutical, Inc.	—	—	view →
2026-08-24	SCHEDULE 13G	Tenaya Therapeutics, Inc.	—	—	view →
2026-06-18	SCHEDULE 13G	Edesa Biotech, Inc. EDSA	—	—	view →
2026-06-17	SCHEDULE 13G	TPG Inc. TPGXL	—	—	view →
2026-06-11	SCHEDULE 13G	Once Upon a Farm, PBC OFRM	—	—	view →
2026-06-10	SCHEDULE 13G	Quince Therapeutics, Inc. QNCX	—	—	view →
2026-05-26	SCHEDULE 13G	Amanat Acquisition Corp AMAN	—	—	view →
2018-01-08	SC	TETRAPHASE PHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →